XRTX
XORTX Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.42M
P/E Ratio
—
EPS
$-2.80
Beta
0.09
52W High
$7.05
52W Low
$1.73
50-Day MA
$2.24
200-Day MA
$3.15
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.96
PEG Ratio
—
About XORTX Therapeutics Inc
XORTX Therapeutics Inc., a biopharmaceutical company, is dedicated to the development and commercialization of therapies to treat progressive kidney disease, hypertension, insulin resistance, and diabetic nephropathy. The company is headquartered in Vancouver, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-2.51M |
| Operating Margin | 0.00% |
| Return on Equity | -98.00% |
| Return on Assets | -46.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.30 |
| Price-to-Book | 2.06 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.09 |
| Quarterly Earnings Growth (YoY) | -97.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.55M |
| Float | $1.37M |
| % Insiders | 10.26% |
| % Institutions | 5.87% |
Historical Volatility
HV 10-Day
122.27%
HV 20-Day
168.72%
HV 30-Day
146.22%
HV 60-Day
121.67%
HV Rank
86.9%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/2/2026